Navigation Links
American Oriental Bioengineering Announces Participation in November Healthcare Conferences
Date:10/26/2007

NEW YORK, Oct. 26 /PRNewswire-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: AOB), a leading manufacturer and distributor of plant-based pharmaceutical and nutraceutical products in China, today announced that the Company will attend several investor conferences in November.

The Company will present at the CIBC World Markets 18th Annual Healthcare Conference on Tuesday, November 6, 2007 at the Waldorf-Astoria Hotel in New York City. Management is currently scheduled to present at 1:55 p.m. ET. On November 15th & 16th, & 19th, management will be meeting with institutional investors at the Credit Suisse China Healthcare Sector Tour in New York City, Boston and London.

The Company will also attend the Lazard Capital Markets Healthcare Conference on November 27-28th and the Piper Jaffray Healthcare Conference on November 27-29th. Both events will take place in New York City.

Institutional investors who are interested in attending these events should contact their institutional sales representatives.

About American Oriental Bioengineering, Inc.

American Oriental Bioengineering is a leading, fully integrated, plant based pharmaceutical and plant based nutraceutical company dedicated to improving health through the development, manufacture and commercialization of modernized plant based products in China.

Safe Harbor Statement

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. Thes
'/>"/>

SOURCE American Oriental Bioengineering, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Abstain from sex- the latest mantra of American teens
2. Clintons new problem - Is the outgoing American president suffering from skin cancer?
3. American scientists alter gene makeup of babies
4. FDA attacks American Red Cross for blood violations
5. Poll Finds Many Americans Misinformed About Cancer
6. Poll Finds Many Americans Misinformed About Cancer
7. Hypertension Drug of Choice for African Americans
8. 38 million Americans including 14 million children left to combat hunger
9. Americans Consume Far Too Much Salt and Sodium
10. Americans Growing Out Of Shape
11. Rise in Stress among Americans
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Obesity and Inactivity -- The Biggest Threat to the Nation's Health 2Health News:Obesity and Inactivity -- The Biggest Threat to the Nation's Health 3Health News:NVHR Offers Congressman Hank Johnson Support & Encouragement as He Battles Chronic Hepatitis C Virus 2Health News:Unanimous Vote Creates Largest RN Union in U.S. History 2Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 2Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 3Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 4Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 5Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 6Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 7Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 8Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 9Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 10Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 11Health News:Senator Ben Nelson Puts U.S. Bishops' Interests Ahead of Americans' Healthcare Needs 2
Breaking Medicine Technology:Inability of Pixantrone to Form Toxic Iron Complexes Results in Significant Reduction in Cardiac Cell Toxicity Compared to Currently Marketed Anthracyclines 2Inability of Pixantrone to Form Toxic Iron Complexes Results in Significant Reduction in Cardiac Cell Toxicity Compared to Currently Marketed Anthracyclines 3Inability of Pixantrone to Form Toxic Iron Complexes Results in Significant Reduction in Cardiac Cell Toxicity Compared to Currently Marketed Anthracyclines 4Pivotal Trial Data Demonstrate NeuroPace RNS(R) System Reduced Seizures in People With Epilepsy 2Pivotal Trial Data Demonstrate NeuroPace RNS(R) System Reduced Seizures in People With Epilepsy 3Pivotal Trial Data Demonstrate NeuroPace RNS(R) System Reduced Seizures in People With Epilepsy 4Roche Diagnostics Opens State-of-the-Art Training Center in California 2American Cancer Society report describes unique cancer profile of Hispanic Latino Americans 57135 1American Cancer Society report describes unique cancer profile of Hispanic Latino Americans 57135 2American Cancer Society report describes unique cancer profile of Hispanic Latino Americans 57135 3Cell Therapeutics Inc 28CTI 29 Advances Pixantrone Filing Process in Europe 3B Submits Pediatric Investigation Plan 28PIP 29 14039 1Cell Therapeutics Inc 28CTI 29 Advances Pixantrone Filing Process in Europe 3B Submits Pediatric Investigation Plan 28PIP 29 14039 2Cell Therapeutics Inc 28CTI 29 Advances Pixantrone Filing Process in Europe 3B Submits Pediatric Investigation Plan 28PIP 29 14039 3Supplementing babies formula with DHA boosts cognitive development 9924 1Supplementing babies formula with DHA boosts cognitive development 9924 2